Search Within

Noah Michael Goodman-Davis

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (1)
Groups
  1. Advanced Practice Providers (1)
  2. Biostatistics Service (1)
  3. Center for Pancreatic Cancer Research (1)
  4. Department of Medicine (1)
  5. Epidemiology and Biostatistics (1)
  6. Gastrointestinal Oncology Service (1)

More Groups

People
  1. David Kelsen (1)
  2. Diane Reidy (1)
  3. Ellen Hollywood (1)
  4. Ki Chung (1)
  5. Leonard Saltz (1)
  6. Marinela Capanu (1)

More People

Years
  1. 2009 (1)
Publications
  1. Journal of Clinical Oncology (1)
Publishers
  1. American Society of Clinical Oncology (1)

Results (1)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)
    Meeting Abstract

    Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save